Armin Schulz
Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.
After graduating, he worked as an IT consultant for a listed company before becoming self-employed, during which time he worked for various DAX-listed companies and a large Swiss insurance company, among others.
Since 2009, he has been exclusively involved in the capital markets, where he was able to gain experience as a day and swing trader, in investor relations and at board level. He was able to live out his passion for numbers in the controlling department of a securities trading house.
For him, fundamental analysis paired with the correct reading of the price action of a market provides the basis for successful trading.
Commented by Armin Schulz
Commented by Armin Schulz on August 21st, 2023 | 08:15 CEST
BYD, First Phosphate, JinkoSolar - Benefiting from the growing energy storage market
The electrification of the world is an important step in reducing dependence on fossil fuels and achieving climate goals. Energy storage systems and batteries are essential to balance the fluctuating generation from renewable energy sources such as solar and wind. They can store excess electricity and release it when needed. One promising technology for electricity storage and rechargeable batteries is lithium-iron-phosphate (LFP) batteries, which are safer and cheaper than traditional lithium-ion batteries and have a longer service life. Moreover, the first automakers are exploring the usability of LFP batteries. The market for energy storage is growing rapidly. We take a look at three companies that stand to benefit from developments in the energy storage market.
Read
Commented by Armin Schulz on August 16th, 2023 | 05:40 CEST
BioNTech, Defence Therapeutics, Bayer - Who will have trend-setting news first?
Pharmaceutical and biotech stocks are among the most volatile sectors in the financial markets. Single news stories about new developments or product announcements can not only cause short-term price swings but also have long-term implications, increasing both risk and opportunity for investors. If a breakthrough drug is developed, old preparations can become obsolete - this is good for the innovative company but detrimental to established market participants. As an investor, it is advisable to select specific companies and anticipate directional news through some research.
Read
Commented by Armin Schulz on August 15th, 2023 | 05:50 CEST
Commerzbank, Viva Gold, Plug Power - What is next for the markets?
While the FED will probably take a break after its last interest rate hike to 5.5%, the ECB could be forced to turn the interest rate screw further, as inflation is only slowly declining. From May to June, the inflation rate in Germany climbed to 6.4%, only to fall back to 6.2% in July. The banking crisis seems to have been overcome after the turbulence between early February and mid-March. An end to the interest rate hike could have a positive effect on the gold price. Another catalyst is the meeting of the BRICS countries on August 22-24, which could decide on a new gold-backed currency. For growth companies, higher interest rates are poison as borrowed money is now much more expensive. We have selected one company from each segment.
Read
Commented by Armin Schulz on August 9th, 2023 | 08:55 CEST
Infineon, Globex Mining, PayPal - Where is it worth getting in after the setback?
The world of finance is characterized by constant fluctuations and changes. This dynamic, which is a source of uncertainty for some investors, can also provide opportunities to profit for well-informed shareholders. One such approach to profiting from the ups and downs of the financial markets is the art of "Buy the Dip" - taking advantage of setbacks or downturns in stock prices to invest cheaply in promising companies. This approach requires a solid understanding of market behavior and the ability to distinguish between temporary price corrections and long-term value potential. We have selected three candidates where an entry could be worthwhile.
Read
Commented by Armin Schulz on August 7th, 2023 | 07:00 CEST
BP, Saturn Oil + Gas, Shell - Gains due to rising oil prices
The price of crude oil rose again last week. While Brent went out of trading on Friday at USD 85.45, the price for WTI stood at USD 81.53 per barrel. This could just be the beginning, as both Saudi Arabia and Russia have cut back production, which has tightened supply. In addition, US oil reserves fell by an unprecedented 17.1 million barrels, the most significant drop ever recorded. Only the downgrade of the US credit rating weighed a little on sentiment. But the risk that this will weigh on the economy seems small. The FED has let it be known that interest rates are not to rise for the time being, inflation is falling, and many company figures are above analysts' expectations. We, therefore, look at three oil producers that benefit from a rising oil price.
Read
Commented by Armin Schulz on August 2nd, 2023 | 09:30 CEST
Barrick Gold, Desert Gold, Deutsche Bank - Revolution through a new gold-backed currency?
As expected, last week, the FED and the ECB raised interest rates by 0.25% each in an effort to further fight inflation. The US dollar also showed strength. These factors are typically considered negative signals for the gold price, yet gold futures recently rallied and are preparing to test the all-time high. What could be the reason for this? One possible explanation could be the meeting of BRICS countries in Johannesburg from August 22 to 24. There are rumors that the participants want to introduce a new gold-backed currency to compete with the US dollar. Such a move could drive the price of gold to unprecedented heights. Additionally, many central banks have been increasing their gold purchases recently.
Read
Commented by Armin Schulz on July 31st, 2023 | 09:20 CEST
Bayer, Defense Metals, Alibaba - Stocks with doubling potential
Discovering stocks with high growth potential during difficult market periods is a challenging task. While there is no guarantee that a stock will double in value, certain factors can help identify companies with promising growth prospects. One effective approach is to focus on industries that offer growth opportunities even in adverse market conditions. Otherwise, examining fundamentals and ensuring the story fits the current spirit of the times is advisable. We have selected three possible doubling candidates.
Read
Commented by Armin Schulz on July 27th, 2023 | 07:15 CEST
BioNTech, Defiance Silver, Vonovia - Waiting for the turnaround
The stock market is not a one-way street, so it happens time and again that companies that initially performed well run into problems, leading to falling prices. After an extended period of underperformance, bargain hunters often step in, seeking the right entry point to profit from a potential turnaround. One announcement can turn the tide and influence the price of a stock. We have selected three candidates where a turnaround could be imminent, provided an appropriate news catalyst exists.
Read
Commented by Armin Schulz on July 25th, 2023 | 10:05 CEST
Manuka Resources, JinkoSolar, BYD - Vanadium, a critical raw material in the energy transition
The energy transition is a crucial step towards a sustainable energy supply. The storage of solar energy and the optimization of batteries for electric vehicles are important topics in this context. Vanadium can play a key role in these areas. The critical raw material is used in the battery industry as a cathode material in redox flow batteries, primarily for energy storage. Whether vanadium will also find its way into batteries for electric vehicles remains to be seen. Originally, the material was used as an important alloying metal in structural and tool steels to refine the steel.
Read
Commented by Armin Schulz on July 19th, 2023 | 07:45 CEST
Pfizer, Cardiol Therapeutics, Bayer - Pharma facing turnaround despite drug shortages?
In mid-June, there was a shortage of 470 prescription drugs in Germany, according to the Federal Institute for Drugs and Medical Devices. However, not only Germany is suffering from a shortage, but all of Europe. Once again, the dependence on China is the underlying cause. The EU is seeking countermeasures, but this will be challenging because capped prices, bureaucracy and rising energy costs make a location like Germany seem less attractive. At the same time, demographic change means that society needs the pharmaceutical industry more and more urgently. Therefore, we look at three companies that aim to heal sick people.
Read